Targeting danger-associated molecular patterns after myocardial infarction (Q38595544)

4 September 2017

title

Targeting danger-associated molecular patterns after myocardial infarction (English)

1 reference

4 September 2017

3

Gerard Pasterkamp

1 reference

4 September 2017

4

Imo E Hoefer

1 reference

4 September 2017

author name string

Gerardus P J van Hout

series ordinal

1

1 reference

4 September 2017

Fatih Arslan

series ordinal

2

1 reference

4 September 2017

language of work or name

English

0 references

publication date

30 September 2015

1 reference

Expert Opinion on Therapeutic Targets

4 September 2017

published in

1 reference

4 September 2017

volume

20

1 reference

4 September 2017

issue

2

1 reference

4 September 2017

page(s)

223-239

1 reference

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The inflammatory response in myocardial injury, repair, and remodelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The innate immune response in reperfused myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-Like Receptors and Myocardial Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Inflammasomes and their roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

High mobility group [corrected] box 1 mediates neutrophil recruitment in myocardial ischemia-reperfusion injury through toll like receptor 4-related pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Effect of carvedilol on cardiomyocyte apoptosis in a rat model of myocardial infarction: a role for toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The Toll-like Receptor 9 Ligand CPG-C Attenuates Acute Inflammatory Cardiac Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Activation and regulation of the inflammasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

NLRP3 inflammasome as a novel player in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Targeting interleukin-1 in heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cellular signalling of the receptor for advanced glycation end products (RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Danger signals in the initiation of the inflammatory response after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cutting edge: cardiac myosin activates innate immune responses through TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The origin and properties of extracellular DNA: from PAMP to DAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Circulating mitochondrial DAMPs cause inflammatory responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Protein synthesis in salivary glands of Drosophila melanogaster: relation to chromosome puffs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

A new puffing pattern induced by temperature shock and DNP in drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Functions of heat shock proteins in pathways of the innate and adaptive immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mechanisms of the Hsp70 chaperone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

21 January 2018

Sensing necrotic cells

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Extracellular heat shock protein 60, cardiac myocytes, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Small Heat Shock Proteins and Protection Against Ischemic Injury in Cardiac Myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The functions of HMGB1 depend on molecular localization and post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Structural features of the HMG chromosomal proteins and their genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

High-mobility group box-1 in sterile inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Role of HMGB1 in apoptosis-mediated sepsis lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Exendin-4 attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The extra domain A of fibronectin activates Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

21 January 2018

S100 proteins in cancer

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Functions of S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A9 interaction with TLR4 promotes tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The IL-1 family: regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The role of IL-1 in the pathogenesis of heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cutting edge: IL-1α is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Anakinra in experimental acute myocardial infarction--does dosage or duration of treatment matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Interleukin-18 mediates interleukin-1-induced cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Innate immune signaling in cardiac ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

TLR2 and TLR4 in ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Limitation of myocardial infarct size by superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Myocardial reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Monocyte and macrophage heterogeneity in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cardioprotection: chances and challenges of its translation to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Alarmin HNP-1 promotes pyroptosis and IL-1β release through different roles of NLRP3 inflammasome via P2X7 in LPS-primed macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Biglycan is required for adaptive remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Postischemic infusion of sivelestat sodium hydrate, a selective neutrophil elastase inhibitor, protects against myocardial stunning in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Targeting osteopontin, the silent partner of Na /H exchanger isoform 1 in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2 manifest delayed parturition and decreased expression of inflammatory and contractile genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Versican is induced in infiltrating monocytes in myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.2016.1088005

10.1517/14728222.2016.1088005

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference